Financials

  • Market Capitalization 84.19 M
  • Employee 9
  • Founded 2018
  • CEO N/A
  • Website www.rallybio.com
  • Headquarter Delaware, United States
  • FIGI BBG011PFKF54
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.45
ratio cours/chiffre d'affaires
36.01

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4055
NRXS
Neuraxis, Inc. Common Stock
6.88 USD-3.64%-7.28%-1.15%+26.70%85.20 M USD
4057
ACRV
Acrivon Therapeutics, Inc. - Common Stock
1.98 USD+1.02%+9.39%+27.74%+48.87%84.75 M USD
4086
ENTX
Entera Bio Ltd. - Ordinary Shares
1.64 USD-1.20%-4.65%+31.20%-7.34%80.73 M USD
4087
CSBR
Champions Oncology, Inc. - Common Stock
5.81 USD-0.17%+1.40%-10.48%-27.83%80.68 M USD

Nouvelles